Healthcare / Health Information ServicesLSE
$2.00
+0.20 (+11.11%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-29.8M · quality 75.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
26/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$9M
P/E
N/A
•EV/EBITDA
N/A
•ROE
291.4%
↑Gross Margin
40.0%
↓Debt/Equity
-1.19
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.3%
FCF CAGR
—
FCF margin
-596.7%
FCF / Net income
0.88x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.0M · net income $-20.4M · FCF $-17.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.0M | $3.0M | $2.3M | $3.4M | $3.0M |
| Net Income | $-20.4M | $-20.4M | $-45.5M | $-45.6M | $-45.3M |
| EBITDA | $-21.3M | $-21.3M | $-43.0M | $-41.7M | $-52.7M |
| EPS | -0.07 | -0.07 | -0.31 | -0.56 | -0.82 |
| Gross Margin | 40.0% | 40.0% | 8.7% | 21.2% | 29.4% |
| Operating Margin | -573.3% | -573.3% | -1326.1% | -1240.7% | -1790.7% |
| Net Margin | -680.0% | -680.0% | -1978.3% | -1340.2% | -1524.4% |
| Balance Sheet | |||||
| Debt/Equity | -1.19 | -1.19 | -0.94 | 1.74 | 0.40 |
| Current Ratio | 1.57 | 1.57 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-17.9M | $-17.9M | $-29.8M | $-34.1M | $-46.6M |
| Returns | |||||
| ROE | 291.4% | 291.4% | 505.6% | -654.6% | -147.9% |
| Valuation | |||||
| P/B | — | — | — | 1386.49 | 255.91 |
| Growth & Yield | |||||
| Revenue Growth | 30.4% | 30.4% | -32.4% | 14.6% | — |
| EPS Growth | 77.4% | 77.4% | 44.6% | 31.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-72.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.31 → -0.07
Residual
-72.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.